Cingulate

Cingulate Enterprise Value

The Enterprise Value (EV) of Cingulate (CING) as of Nov 21, 2026 is 79.98 M USD. In the previous year, Enterprise Value (EV) was 75.04 M USD — a change of 6.59% (higher).

Enterprise Value

79.98 MUSD

YoY

6.59%

Last updated:

Enterprise Value (EV) of Cingulate is 2025 79.98 M USD. Enterprise Value (EV) of Cingulate was 2024 75.04 M USD. It decreases by 6.59% higher compared to the previous year.

The Cingulate Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
83.80 M USD
Jan 1, 2020
83.00 M USD
Jan 1, 2021
66.83 M USD
Jan 1, 2022
82.66 M USD
Jan 1, 2023
85.61 M USD
Jan 1, 2024
75.04 M USD
Jan 1, 2025
79.98 M USD
The Cingulate Enterprise Value history
YEAREnterprise ValueYoY
79.98 MUSD+6.59%
75.04 MUSD-12.35%
85.61 MUSD+3.57%
82.66 MUSD+23.68%
66.83 MUSD-19.48%
83.00 MUSD-0.96%
83.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Enterprise Value (EV) of Cingulate is 79.98 M USD in 2025.

Enterprise Value (EV) of Cingulate changed from 75.04 M USD to 79.98 M USD, representing a 6.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Cingulate since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Cingulate with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cingulate

All Key Metrics — Cingulate